Repotrectinib is an azamacrocycle with formula C18H18FN5O2. It is a tyrosine kinase inhibitor (highly potent against ROS1, TRKA-C, and ALK) used for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer. Among its listed roles, it functions as a EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an antineoplastic agent. It belongs to the class of monofluorobenzenes, a pyrazolopyrimidine, a cyclic ether, a secondary carboxamide and an azamacrocycle. It is grouped under the following drug class(es): Kinase inhibitors and Tyrosine Kinase Inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Augtyro, repotrectinibum and Multikinase Inhibitor TPX-0005. Its PubChem CID is 135565923.
Repotrectinib
| CAS No | 1802220-02-5 |
|---|---|
| Molecular Formula | C18H18FN5O2 |
| Molecular Weight | 355.4 g/mol |
| Synonyms | (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Repotrectinib is an azamacrocycle with formula C18H18FN5O2. It is a tyrosine kinase inhibitor (highly potent against ROS1, TRKA-C, and ALK) used for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer.
The listed CAS number is 1802220-02-5.
The listed molecular formula is C18H18FN5O2.
The listed molecular weight is 355.4 g/mol.
(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one.
The source lists Augtyro, repotrectinibum and Multikinase Inhibitor TPX-0005.